查詢結果分析
來源資料
相關文獻
- 免疫調整配方對加護病房患者營養狀況及發炎反應指標之影響
- 白血病兒童修正版症狀評估量表之信效度
- 血清前白蛋白作為接受放射治療中的頭頸部腫瘤病患之營養指標
- 前白蛋白、鐵轉移蛋白和視黃醇結合蛋白﹣﹣最近早產兒營養評估的指標
- Efficacy of Medium-chain Triglycerides Compared with Long-chain Triglycerides in Total Parenteral Nutrition in Patients with Digestive Tract Cancer Undergoing Surgery
- 免疫調節配方對加護病房患者淋巴球分佈及白血球黏著分子表現之影響
- 使用前白蛋白探討外科加護病房病人預後
- 腹膜透析病人的潛在性發炎狀況與腹膜炎發生之相關性
- 白色中國鵝及白羅曼鵝之血清蛋白質量與成分之比較
- Airway Hyperreactivity Modulated by Immunotherapy with Denatured Ovalbumin in Ovalbumin-Sensitized Guinea Pigs
頁籤選單縮合
題 名 | 免疫調整配方對加護病房患者營養狀況及發炎反應指標之影響=Effects of Immune-modulating Formula on Nutritional Status and Inflammatory Marker in ICU Patients |
---|---|
作 者 | 賴聖如; 林明燦; 趙安怡; 葉松鈴; | 書刊名 | 臺灣營養學會雜誌 |
卷 期 | 31:3 民95.09 |
頁 次 | 頁95-101 |
分類號 | 411.3 |
關鍵詞 | 加護病房患者; 免疫調節配方; 前白蛋白; 白蛋白; C反應蛋白; ICU patients; Immune-modulating formula; Prealbumin; Albumin; C-reactive protein; |
語 文 | 中文(Chinese) |
中文摘要 | 本研究探討免疫調節配方對重症患者是否可改善營養狀況並降低發炎指標。實驗對象為一般外科加護病房中的患者12名,其Acute Physiology and Chronic Health EvaluationⅡ(APACHⅡ)指數為8~15,隨機分成2組每組6名,均經由腸道灌食,實驗組給予兩種免疫調節配方之其中一種(Impact-glutamine或Nu-Immune),此二配方均為添加精胺酸、n-3脂肪酸、麩醱胺之均衡完整配方。對照組則給予一般之高蛋白配方。經灌食一星期後比較兩組間前白蛋白、白蛋白、C反應蛋白、白血球數、APACHⅡ及全身性發炎反應症候群(SIRS)指數之差異性。結果顯示在腸道營養介入前,兩組在年齡、身高、體重、熱量需求、平均攝取量、營養狀況指標、發炎反應指標及疾病嚴重度問均無差異。給予一星期的腸道營養補充後,兩組APACHⅡ指數明顯下降,前白蛋白及白蛋白則顯著上升。實驗組SIRS指數在腸道營養補充後下降,對照組則無差異。本研究結果顯示,中度重症患者,即早給予腸道營養可改善蛋白質營養狀況,並降低APACHⅡ指數。重症患者在使用免疫調節配方後,可降低SIRS指數,但使用免疫調節配方在改善營養狀況及發炎反應指標上與一般均衡配方並無差異。 |
英文摘要 | This study compared the effects of immune-modulating formula (Impact-glutamine or Nu-Immune) and complete balanced formula on the nutritional status and inflammatory markers in intensive care unit (ICU) patients. The immune-modulating formulas contain arginine、n-3 fatty acid and glutamine in addition to complete balanced nutrition. Twelve ICU patients with Acute Physiology and Chronic Health Evaluation Ⅱ (APACH Ⅱ) with score 8~15 were randomly assigned to the control and the test groups with enteral feeding for one week. The control group was fed with a general balanced formula, whereas the test group was fed with either Impact-glutamine or Nu-Immune. Blood samples were collected before and after the experimental period to compare the plasma pre-albumin, albumin, C-reactive protein levels, leukocyte counts, APACH Ⅱ score and systemic inflammatory response syndrome (SIRS) score between groups. The results showed that there were no differences in age, body weight, height, nutritional status and inflammatory markers between the 2 groups before nutritional intervention. However, affer enteral feeding for 7 days, APACH Ⅱ score reduced, While albumin and pre-albumin levels increased, regardless the patients were fed with immune-modulating or general formula. Patients with immune-modulating formula reduced the SIRS score after feeding for 7 days. These results suggest that enteral feeding improved protein status in ICU patients. Formula with specific nutrients supplementation reduced the severity of the diseases. Nevertheless, compared with the general balanced formula, immune-modulating diet had no favorable effects on nutritional status and inflammatory markers in critically ill patients. |
本系統中英文摘要資訊取自各篇刊載內容。